A Phase 4, Open-Label, Single-Arm Study Assessing the Efficacy and Safety of Ivabradine in African American Patients with Heart Failure and Reduced Ejection Fraction

ConclusionThese data support ivabradine use in African American patients with HF with reduced ejection fraction who meet typical treatment criteria.Trial RegistrationClinicalTrials.gov identifier, NCT03456856
Source: Cardiology and Therapy - Category: Cardiology Source Type: research